Dec 16, 2024 12:37 pm
For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why.
A new study published Friday in the journal, JAMA Health Forum, found that obesity numbers ticked down slightly from 46% in 2022 to 45.6% in 2023. While only a slight decline, this is the first drop recorded in at least a decade.